Premium
Sublingual midazolam premedication in children: a dose response study
Author(s) -
Khalil Samia,
Philbrook Lisa,
Rabb Mary,
Wagner Kari,
Jennings Chris,
Chuang Alice Z,
Lemak Noreen A
Publication year - 1998
Publication title -
pediatric anesthesia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.704
H-Index - 82
eISSN - 1460-9592
pISSN - 1155-5645
DOI - 10.1046/j.1460-9592.1998.00286.x
Subject(s) - medicine , midazolam , premedication , anesthesia , placebo , sedation , randomized controlled trial , sedative , swallowing , surgery , alternative medicine , pathology
The purpose of this study was to evaluate various doses of sublingual midazolam premedication in children. In our prospective, double‐blind, placebo‐controlled trial, children ( n =102, age range 12 to 129 months) scheduled for day surgery were randomized to receive either midazolam in one of three doses (0.25, 0.5, or 0.75 mg·kg −1 ) or placebo. Injectable midazolam was mixed with a thick grape syrup and placed under the tongue; the patient was asked to hold it as long as possible before swallowing. Children readily accepted the mixture. Analysing all patients randomized, none of the children receiving placebo vs 28% receiving 0.25 mg·kg −1 ( P =0.02), 52% receiving 0.5 mg·kg −1 ( P <0.001), and 64% receiving 0.75 mg·kg −1 ( P <0.001) of midazolam showed satisfactory sedation (drowsy) at 15 min after administration. Children receiving the two higher doses of midazolam (0.5 and 0.75 mg·kg −1 ) accepted mask induction willingly, while the group receiving 0.25 mg·kg −1 resembled the placebo group ( P <0.05).